Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection
- PMID: 2839723
- PMCID: PMC253753
- DOI: 10.1128/JVI.62.8.3073-3076.1988
Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection
Abstract
Six normal and four immunodeficient horses were injected with a cloned variant of equine infectious anemia virus (EIAV). The six normal horses had detectable EIAV in their plasma by 7 days postinjection. During their primary viremic episode, which was accompanied by fever and anemia, maximum titers of EIAV in plasma ranged from 10(3.8) to 10(4.8) 50% tissue culture infective doses per ml. All six normal horses cleared detectable virus from their plasma by 21 to 35 days after injection. Horses with combined immunodeficiency became viremic by 9 days postinjection and also developed anemia. In contrast to normal horses, foals with combined immunodeficiency did not eliminate the virus from their plasma.
Similar articles
-
Immunologic response to EIAV offers hope for AIDS treatment.J Am Vet Med Assoc. 1992 Dec 1;201(11):1672-3. J Am Vet Med Assoc. 1992. PMID: 1338067 No abstract available.
-
Immunopathogenesis of equine infectious anemia lentivirus disease.Dev Biol Stand. 1990;72:31-7. Dev Biol Stand. 1990. PMID: 2178127 Review.
-
Transient suppression of equine immune responses by equine infectious anemia virus (EIAV).Virology. 1991 Sep;184(1):55-66. doi: 10.1016/0042-6822(91)90821-r. Virology. 1991. PMID: 1651604
-
Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.J Virol. 2004 Sep;78(17):9295-305. doi: 10.1128/JVI.78.17.9295-9305.2004. J Virol. 2004. PMID: 15308724 Free PMC article.
-
Cytotoxic T lymphocytes in protection against equine infectious anemia virus.Anim Health Res Rev. 2004 Dec;5(2):271-6. doi: 10.1079/ahr200482. Anim Health Res Rev. 2004. PMID: 15984338 Review.
Cited by
-
Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.Viruses. 2013 Dec 2;5(12):2963-76. doi: 10.3390/v5122963. Viruses. 2013. PMID: 24316675 Free PMC article. Review.
-
Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.J Virol. 1998 Dec;72(12):9612-20. doi: 10.1128/JVI.72.12.9612-9620.1998. J Virol. 1998. PMID: 9811694 Free PMC article.
-
The immunopathogenesis of equine infectious anemia virus.Virus Res. 1994 May;32(2):111-38. doi: 10.1016/0168-1702(94)90038-8. Virus Res. 1994. PMID: 8067050 Free PMC article. Review. No abstract available.
-
Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.J Virol. 2011 Jul;85(13):6814-8. doi: 10.1128/JVI.00077-11. Epub 2011 May 4. J Virol. 2011. PMID: 21543497 Free PMC article.
-
Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.J Virol. 1994 Apr;68(4):2362-70. doi: 10.1128/JVI.68.4.2362-2370.1994. J Virol. 1994. PMID: 8139022 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources